Pharma

Your Article Summary

See Latest Articles

Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Amgen, 09/22/09

Amgen announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors or multiple myeloma.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials